|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/155 | |
| A61K 31/5383 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2945618 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14702159.6 |
| Europos patento paraiškos padavimo data | 2014-01-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-06-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/011394 |
| Data | 2014-01-14 |
| (87) | Numeris | WO 2014/113357 |
| Data | 2014-07-24 |
| (30) | Numeris | Data | Šalis |
| 201361753567 P | 2013-01-17 | US |
| (72) |
MJALLI, Adnan M.M., US
CLARK, Bradley Alan, US
POLISETTI, Dharma Rao, US
QUADA, JR., James C., US
VALCARCE LOPEZ, Maria Carmen, US
ANDREWS, Robert Carl, US
DAVIS, Stephen Thomas, US
YOKUM, Thomas Scott, US
|
| (73) |
vTv Therapeutics LLC,
4170 Mendenhall Oaks Parkway, High Point, NC 27265,
US
|
| (54) | COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS |
| COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS |